HighVista Strategies LLC - Q2 2022 holdings

$166 Million is the total value of HighVista Strategies LLC's 110 reported holdings in Q2 2022. The portfolio turnover from Q1 2022 to Q2 2022 was 62.8% .

 Value Shares↓ Weighting
DELL  DELL TECHNOLOGIES INCcl c$16,425,000
-7.9%
355,4440.0%9.92%
-12.6%
MA BuyMASTERCARD INCORPORATEDcl a$11,681,000
+35.0%
37,024
+53.0%
7.05%
+28.2%
V BuyVISA INC$8,517,000
-6.6%
43,257
+5.2%
5.14%
-11.3%
FISV BuyFISERV INC$7,681,000
-9.0%
86,334
+3.7%
4.64%
-13.6%
MSDAU  MSD ACQUISITION CORPunit 03/25/2026$4,935,000
-0.1%
500,0000.0%2.98%
-5.2%
KURA BuyKURA ONCOLOGY INC$3,994,000
+68.0%
217,895
+47.4%
2.41%
+59.6%
CHNG  CHANGE HEALTHCARE INC$3,738,000
+5.8%
162,1000.0%2.26%
+0.4%
PYPL BuyPAYPAL HLDGS INC$3,723,000
-36.5%
53,302
+5.1%
2.25%
-39.7%
COHR  COHERENT INC$3,621,000
-2.6%
13,6000.0%2.19%
-7.5%
IWD NewISHARES TRrus 1000 val etf$3,454,00023,825
+100.0%
2.08%
CPNG  COUPANG INCcl a$3,268,000
-27.9%
256,2640.0%1.97%
-31.5%
ATVI  ACTIVISION BLIZZARD INC$3,114,000
-2.8%
40,0000.0%1.88%
-7.7%
CTXS  CITRIX SYS INC$3,051,000
-3.7%
31,4000.0%1.84%
-8.6%
ACRS BuyACLARIS THERAPEUTICS INC$3,037,000
+11.3%
217,528
+37.5%
1.83%
+5.7%
TGNA NewTEGNA INC$3,019,000144,000
+100.0%
1.82%
TPTX BuyTURNING POINT THERAPEUTICS I$2,964,000
+424.6%
39,384
+87.2%
1.79%
+398.3%
FHN  FIRST HORIZON CORPORATION$2,960,000
-6.9%
135,4000.0%1.79%
-11.6%
FATE BuyFATE THERAPEUTICS INC$2,943,000
+17.4%
118,778
+83.7%
1.78%
+11.5%
CYTK BuyCYTOKINETICS INC$2,652,000
+9.5%
67,502
+2.6%
1.60%
+4.0%
BCYC BuyBICYCLE THERAPEUTICS PLCsponsored ads$2,537,000
+215.9%
151,207
+726.4%
1.53%
+199.8%
TVTX BuyTRAVERE THERAPEUTICS INC$2,524,000
+201.2%
104,150
+220.5%
1.52%
+185.9%
TWTR NewTWITTER INC$2,393,00064,000
+100.0%
1.44%
GBT BuyGLOBAL BLOOD THERAPEUTICS IN$2,373,000
+34.1%
74,261
+45.4%
1.43%
+27.4%
RPTX BuyREPARE THERAPEUTICS INC$2,135,000
+4.6%
152,600
+6.4%
1.29%
-0.7%
APLS BuyAPELLIS PHARMACEUTICALS INC$2,086,000
+11.3%
46,141
+25.1%
1.26%
+5.6%
CPARU  CATALYST PARTNRS ACQUISITN Cunit 99/99/9999$1,954,000
-3.3%
200,0000.0%1.18%
-8.1%
NVCR BuyNOVOCURE LTD$1,946,000
+34.6%
28,007
+60.5%
1.18%
+27.9%
RLAY BuyRELAY THERAPEUTICS INC$1,898,000
-7.5%
113,313
+65.2%
1.15%
-12.2%
RCUS BuyARCUS BIOSCIENCES INC$1,816,000
+14.9%
71,650
+43.2%
1.10%
+9.1%
IDYA BuyIDEAYA BIOSCIENCES INC$1,799,000
+224.7%
130,380
+163.3%
1.09%
+208.5%
BMEA BuyBIOMEA FUSION INC$1,734,000
+244.0%
144,727
+28.2%
1.05%
+227.2%
DYN BuyDYNE THERAPEUTICS INC$1,662,000
+2.2%
241,867
+43.4%
1.00%
-3.0%
GBIO BuyGENERATION BIO CO$1,633,000
+69.4%
248,994
+89.6%
0.99%
+60.8%
CBAY BuyCYMABAY THERAPEUTICS INC$1,166,000
+80.8%
395,332
+90.7%
0.70%
+71.7%
KPTI NewKARYOPHARM THERAPEUTICS INC$1,129,000250,377
+100.0%
0.68%
DBC  INVESCO DB COMMDY INDX TRCKunit$1,129,000
+2.2%
42,3960.0%0.68%
-3.0%
MSFT NewMICROSOFT CORP$1,024,0003,988
+100.0%
0.62%
FOLD SellAMICUS THERAPEUTICS INC$969,000
-5.5%
90,234
-16.6%
0.58%
-10.3%
BBIO BuyBRIDGEBIO PHARMA INC$962,000
+11.1%
105,942
+24.2%
0.58%
+5.4%
MRUS BuyMERUS N V$916,000
+14.1%
40,481
+33.2%
0.55%
+8.2%
KDNY SellCHINOOK THERAPEUTICS INC$889,000
-19.8%
50,834
-25.0%
0.54%
-23.8%
IMGN BuyIMMUNOGEN INC$863,000
+133.2%
191,726
+146.8%
0.52%
+121.7%
EWTX BuyEDGEWISE THERAPEUTICS INC$824,000
+42.3%
103,462
+73.2%
0.50%
+35.1%
ARGX SellARGENX SEsponsored adr$816,000
-15.4%
2,153
-29.7%
0.49%
-19.7%
UTHR BuyUNITED THERAPEUTICS CORP DEL$813,000
+70.4%
3,452
+29.9%
0.49%
+62.0%
BEAM BuyBEAM THERAPEUTICS INC$812,000
+27.7%
20,980
+89.0%
0.49%
+21.3%
GOSS BuyGOSSAMER BIO INC$810,000
+33.2%
96,795
+38.2%
0.49%
+26.4%
KRYS NewKRYSTAL BIOTECH INC$803,00012,225
+100.0%
0.48%
CERE NewCEREVEL THERAPEUTICS HLDNG I$752,00028,450
+100.0%
0.45%
MRTX BuyMIRATI THERAPEUTICS INC$745,000
-7.1%
11,096
+13.8%
0.45%
-11.8%
AMRN BuyAMARIN CORP PLCspons adr new$746,000
-52.4%
500,680
+5.0%
0.45%
-54.9%
ARQT NewARCUTIS BIOTHERAPEUTICS INC$734,00034,462
+100.0%
0.44%
ALNY SellALNYLAM PHARMACEUTICALS INC$728,000
-19.7%
4,988
-10.2%
0.44%
-23.7%
SRPT SellSAREPTA THERAPEUTICS INC$718,000
-18.8%
9,581
-15.3%
0.43%
-23.0%
BMRN BuyBIOMARIN PHARMACEUTICAL INC$712,000
+65.2%
8,596
+53.7%
0.43%
+56.9%
ASND SellASCENDIS PHARMA A/Ssponsored adr$692,000
-24.6%
7,442
-4.8%
0.42%
-28.4%
XENE SellXENON PHARMACEUTICALS INC$682,000
-20.3%
22,435
-19.9%
0.41%
-24.3%
ANAB BuyANAPTYSBIO INC$672,000
+94.2%
33,103
+136.5%
0.41%
+84.5%
TCDA SellTRICIDA INC$664,000
-24.6%
68,548
-36.1%
0.40%
-28.4%
ARVN NewARVINAS INC$660,00015,686
+100.0%
0.40%
GLPG SellGALAPAGOS NVspon adr$658,000
-19.7%
11,801
-10.7%
0.40%
-23.8%
GOOG NewALPHABET INCcap stk cl c$647,000296
+100.0%
0.39%
GHRS BuyGH RESEARCH PLCordinary shares$638,000
-34.0%
63,936
+21.0%
0.38%
-37.3%
MORF BuyMORPHIC HLDG INC$634,000
+44.7%
29,230
+167.7%
0.38%
+37.8%
NTRA BuyNATERA INC$631,000
+15.4%
17,812
+32.5%
0.38%
+9.5%
CRNX SellCRINETICS PHARMACEUTICALS IN$614,000
-36.8%
32,948
-25.5%
0.37%
-39.9%
BPMC NewBLUEPRINT MEDICINES CORP$612,00012,108
+100.0%
0.37%
PCVX NewVAXCYTE INC$609,00027,965
+100.0%
0.37%
CLDX SellCELLDEX THERAPEUTICS INC NEW$604,000
-31.1%
22,412
-12.9%
0.36%
-34.6%
HZNP SellHORIZON THERAPEUTICS PUB L$592,000
-31.9%
7,419
-10.1%
0.36%
-35.3%
ACAD BuyACADIA PHARMACEUTICALS INC$562,000
-32.0%
39,900
+17.0%
0.34%
-35.4%
RLMD BuyRELMADA THERAPEUTICS INC$560,000
-2.9%
29,493
+37.9%
0.34%
-7.9%
ISEE BuyIVERIC BIO INC$557,000
-38.2%
57,919
+8.1%
0.34%
-41.4%
AMZN NewAMAZON COM INC$538,0005,068
+100.0%
0.32%
VRDN SellVIRIDIAN THERAPEUTICS INC$521,000
-42.6%
45,039
-8.2%
0.32%
-45.4%
IOVA SellIOVANCE BIOTHERAPEUTICS INC$496,000
-45.3%
44,962
-17.4%
0.30%
-48.1%
SWTX BuySPRINGWORKS THERAPEUTICS INC$470,000
+7.3%
19,080
+146.0%
0.28%
+2.2%
KROS BuyKEROS THERAPEUTICS INC$459,000
-47.4%
16,623
+3.6%
0.28%
-50.0%
PTC NewPTC INC$458,0004,310
+100.0%
0.28%
RGNX NewREGENXBIO INC$404,00016,352
+100.0%
0.24%
RVMD NewREVOLUTION MEDICINES INC$403,00020,685
+100.0%
0.24%
ITOS SellITEOS THERAPEUTICS INC$390,000
-46.9%
18,913
-17.1%
0.24%
-49.7%
PTGX SellPROTAGONIST THERAPEUTICS INC$367,000
-83.2%
46,459
-49.5%
0.22%
-84.0%
NBIX NewNEUROCRINE BIOSCIENCES INC$367,0003,767
+100.0%
0.22%
RNA SellAVIDITY BIOSCIENCES INC$361,000
-63.2%
24,864
-53.2%
0.22%
-65.1%
NOW NewSERVICENOW INC$348,000732
+100.0%
0.21%
TMUS NewT-MOBILE US INC$348,0002,588
+100.0%
0.21%
MDGL BuyMADRIGAL PHARMACEUTICALS INC$344,000
-22.5%
4,800
+6.1%
0.21%
-26.2%
BLU SellBELLUS HEALTH INC NEW$336,000
-25.0%
36,364
-44.2%
0.20%
-28.8%
PMVP NewPMV PHARMACEUTICALS INC$332,00023,324
+100.0%
0.20%
BILI NewBILIBILI INCspons ads rep z$327,00012,770
+100.0%
0.20%
JD NewJD.COM INCspon adr cl a$327,0005,098
+100.0%
0.20%
RXDX NewPROMETHEUS BIOSCIENCES INC$304,00010,782
+100.0%
0.18%
ADSK NewAUTODESK INC$303,0001,766
+100.0%
0.18%
IMAB BuyI MABsponsored ads$300,000
-27.4%
26,534
+4.5%
0.18%
-31.2%
BCOR NewBLUCORA INC$293,00015,872
+100.0%
0.18%
WLTW NewWILLIS TOWERS WATSON PLC LTD$291,0001,474
+100.0%
0.18%
ALV NewAUTOLIV INC$281,0003,914
+100.0%
0.17%
CRM NewSALESFORCE INC$277,0001,676
+100.0%
0.17%
EXPE NewEXPEDIA GROUP INC$246,0002,592
+100.0%
0.15%
NOAH NewNOAH HLDGS LTDspon ads cl a$225,00011,116
+100.0%
0.14%
SCPL NewSCIPLAY CORPORATIONcl a$222,00015,922
+100.0%
0.13%
DDOG NewDATADOG INC$220,0002,310
+100.0%
0.13%
XPO NewXPO LOGISTICS INC$220,0004,562
+100.0%
0.13%
NewWARBY PARKER INC$220,00019,550
+100.0%
0.13%
CIXX NewCI FINL CORP$220,00020,658
+100.0%
0.13%
TEAM NewATLASSIAN CORP PLCcl a$221,0001,178
+100.0%
0.13%
KSS NewKOHLS CORP$218,0006,106
+100.0%
0.13%
CHTR NewCHARTER COMMUNICATIONS INC Ncl a$211,000450
+100.0%
0.13%
IQ NewIQIYI INCsponsored ads$157,00037,518
+100.0%
0.10%
VERV ExitVERVE THERAPEUTICS INC$0-14,073
-100.0%
-0.20%
GRTS ExitGRITSTONE BIO INC$0-88,318
-100.0%
-0.23%
BGNE ExitBEIGENE LTDsponsored adr$0-2,002
-100.0%
-0.24%
VTGN ExitVISTAGEN THERAPEUTICS INC$0-315,880
-100.0%
-0.25%
PRTA ExitPROTHENA CORP PLC$0-12,953
-100.0%
-0.30%
NVTA ExitINVITAE CORP$0-75,472
-100.0%
-0.38%
NGM ExitNGM BIOPHARMACEUTICALS INC$0-46,243
-100.0%
-0.45%
RCKT ExitROCKET PHARMACEUTICALS INC$0-48,191
-100.0%
-0.49%
CCCC ExitC4 THERAPEUTICS INC$0-34,760
-100.0%
-0.54%
ExitDICE THERAPEUTICS INC$0-48,960
-100.0%
-0.60%
VRTX ExitVERTEX PHARMACEUTICALS INC$0-3,752
-100.0%
-0.62%
BHVN ExitBIOHAVEN PHARMACTL HLDG CO L$0-12,678
-100.0%
-0.96%
CERN ExitCERNER CORP$0-37,300
-100.0%
-2.22%
FIS ExitFIDELITY NATL INFORMATION SV$0-38,303
-100.0%
-2.44%
PBCT ExitPEOPLES UNITED FINANCIAL INC$0-196,100
-100.0%
-2.49%
Original filings

The following EDGAR filing(s) were analyzed to create this report:

  • View 13F-HR filed 2022-08-15
Signatures

The EDGAR filing(s) were signed by:

Top long-term holdings
NameQuarters ownedLatest quarter ownedMax weighting
TRANSDIGM GROUP INC29Q2 20232.9%
VANGUARD INDEX FDS24Q4 201926.4%
APPLE INC24Q4 20192.0%
ISHARES TR22Q3 20187.9%
MICROSOFT CORP21Q3 20232.0%
VISA INC20Q3 20235.8%
INVESCO DB COMMDY INDX TRCK20Q3 202316.6%
VERIZON COMMUNICATIONS INC20Q4 20190.4%
ALIBABA GROUP HLDG LTD19Q3 20237.7%
AMAZON COM INC19Q3 20232.9%

View HighVista Strategies LLC's complete holdings history.

Latest significant ownerships (13-D/G)
HighVista Strategies LLC Q2 2022 significant holdings filed using form 13D/G when ownership exceeds 5% of a company's total stock issue.
FiledShares Percentage
STG Group, Inc.Sold outFebruary 16, 201600.0%
SAExploration Holdings, Inc.February 12, 201425,0000.2%
Trio Merger Corp.February 14, 2013690,0008.8%

View HighVista Strategies LLC's complete significant-ownership history.

Latest filings
TypeFiled
13F-HR2024-02-14
13F-HR2023-11-14
13F-HR2023-08-14
13F-HR2023-05-15
13F-HR2023-02-14
13F-HR2022-11-14
13F-HR2022-08-15
13F-HR2022-05-16
13F-HR2022-02-14
13F-HR2021-11-15

View HighVista Strategies LLC's complete filings history.

Compare quarters

Export HighVista Strategies LLC's holdings